This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ajou University Industry-Academic Cooperation Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kyoung-Je Jang: Innovator in Tissue Regeneration
Introduction
Kyoung-Je Jang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of tissue regeneration, particularly through his innovative patent related to chronic tympanic perforation treatment.
Latest Patents
Kyoung-Je Jang holds a patent for a "PCL patch tissue regeneration scaffold and method for manufacturing same." This patent discloses a method of treating chronic tympanic perforation using a PCL patch tissue regeneration scaffold. The process involves preparing a solution by adding polycaprolactone (PCL) and an acid to an organic solvent. An electrospinning solution is then created by adding a growth factor to the solution and stirring. The nanofibers are collected in a spindle shape on a collector by connecting the electrospinning solution to a syringe pump and operating the electrospinning device. Finally, the PCL patch tissue regeneration scaffold is administered to a subject.
Career Highlights
Kyoung-Je Jang is affiliated with the Ajou University Industry-Academic Cooperation Foundation, where he continues to advance his research and innovations in tissue engineering. His work has garnered attention for its potential applications in medical treatments.
Collaborations
He collaborates with notable colleagues, including Yun-Hoon Choung and Jong Hoon Chung, who contribute to his research endeavors and enhance the impact of his innovations.
Conclusion
Kyoung-Je Jang is a key figure in the field of tissue regeneration, with a focus on innovative solutions for medical challenges. His contributions through patents and collaborations highlight his commitment to advancing healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile